Dianthus Therapeutics
DNTH
DNTH
97 hedge funds and large institutions have $366M invested in Dianthus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 22 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.55% less ownership
Funds ownership: 4.55% → 4% (-0.55%)
12% less capital invested
Capital invested by funds: $418M → $366M (-$52.1M)
Holders
97
Holding in Top 10
2
Calls
$1K
Puts
–
Top Buyers
| 1 | +$10.9M | |
| 2 | +$10.6M | |
| 3 | +$1.81M | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$1.8M |
| 5 |
BlackRock
New York
|
+$1.73M |
Top Sellers
| 1 | -$6.23M | |
| 2 | -$1.95M | |
| 3 | -$1.85M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.19M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$1.06M |